MSC-exosomes pretreated by Danshensu extracts pretreating to target the hsa-miR-27a-5p and STAT3-SHANK2 to enhanced antifibrotic therapy

Table 2 Plasmid information

	Start	End	Gene Length (bp)	Annotation	Genestart	Geneend	distancetotss	Sequence(5'-3') (Accession number/Gene ID)	Vector
1–1 SHANK2	70,501,694	70,502,570	877	Promoter (< = 1kb)	70,469,435	70,502,859	289	Supplementary Material Table S1	GPL4-Basic
1–2 SHANK2	70,662,309	70,662,572	264	Promoter (< = 1kb)	70,467,856	70,662,197	− 112	Supplementary Material Table S1	GPL4-Basic
1–3 SHANK2	70,826,550	70,826,863	314	Promoter (< = 1kb)	70,667,839	70,826,757	0	Supplementary Material Table S1	GPL4-Basic
1–4 SHANK2	71,091,166	71,091,396	231	Promoter (1-2kb)	70,896,385	71,092,477	1081	Supplementary Material Table S1	GPL4-Basic
STAT3-homo			2313					NM_139276.3	pcDNA3.1( +)
RL-TK(empty vector)									GPL4-RL

ISSN: 1757-6512